VasDeBlock medical ApS
www.vasdeblock.comThe new contraception method - simple and reversible sterilisation for men. Today, 27% of men worldwide use contraception in one form or another. Many users of contraception ask for an alternative to existing forms e.g. condom, birth control pills or surgery (vasectomy). VasDeBlock is an alternative male contraception method that neither requires surgery nor holds hormones and which is far more practical than condoms. The method is simple and has a significantly lower cost than surgery. Another big advantage is that the fertility quite easily may be restablished. VasDeBlock medical ApS has consulted with doctors in urology and medical device companies to devise a unique way to temporarily stop male fertility by blocking vas deferens and later to restablish normal fertility relatively easy. Doctors specializing in urology have not identified any basic flaws in the method and assume that it can be used in practice by all males. In the Western world, the method must be seen as an alternative to well-known methods of contraception, including surgery which 2-5 million men and 6-10 million women undergo yearly. The company is right now in a phase where the focus is on developing prototypes and conduct in-vivo testing to prove the concept. We are looking for financing from sources willing to contribute to the next steps. Financing may be in the form of grants, loans or direct investments.
Read moreThe new contraception method - simple and reversible sterilisation for men. Today, 27% of men worldwide use contraception in one form or another. Many users of contraception ask for an alternative to existing forms e.g. condom, birth control pills or surgery (vasectomy). VasDeBlock is an alternative male contraception method that neither requires surgery nor holds hormones and which is far more practical than condoms. The method is simple and has a significantly lower cost than surgery. Another big advantage is that the fertility quite easily may be restablished. VasDeBlock medical ApS has consulted with doctors in urology and medical device companies to devise a unique way to temporarily stop male fertility by blocking vas deferens and later to restablish normal fertility relatively easy. Doctors specializing in urology have not identified any basic flaws in the method and assume that it can be used in practice by all males. In the Western world, the method must be seen as an alternative to well-known methods of contraception, including surgery which 2-5 million men and 6-10 million women undergo yearly. The company is right now in a phase where the focus is on developing prototypes and conduct in-vivo testing to prove the concept. We are looking for financing from sources willing to contribute to the next steps. Financing may be in the form of grants, loans or direct investments.
Read moreEmployees statistics
View all employeesPotential Decision Makers
Chief Executive
Email ****** @****.comPhone (***) ****-****Chairman of the Board
Email ****** @****.comPhone (***) ****-****Team Member , Member of the Bod and Seed Investor
Email ****** @****.comPhone (***) ****-****
Technologies
(4)